Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Department of Emergency Medicine, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Front Immunol. 2022 Sep 2;13:943783. doi: 10.3389/fimmu.2022.943783. eCollection 2022.
Basic research for prevention and treatment of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues worldwide. In particular, multiple newly reported cases of autoimmune-related diseases after COVID-19 require further research on coronavirus-related immune injury. However, owing to the strong infectivity of SARS-CoV-2 and the high mortality rate, it is difficult to perform relevant research in humans. Here, we reviewed animal models, specifically mice with coronavirus-related immune disorders and immune damage, considering aspects of coronavirus replacement, viral modification, spike protein, and gene fragments. The evaluation of mouse models of coronavirus-related immune injury may help establish a standardised animal model that could be employed in various areas of research, such as disease occurrence and development processes, vaccine effectiveness assessment, and treatments for coronavirus-related immune disorders. COVID-19 is a complex disease and animal models cannot comprehensively summarise the disease process. The application of genetic technology may change this status.
针对由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19)的基础研究正在全球范围内持续进行。特别是 COVID-19 后出现的多种新报告的自身免疫性疾病病例,需要对冠状病毒相关免疫损伤进行进一步研究。然而,由于 SARS-CoV-2 的强传染性和高死亡率,很难在人类中进行相关研究。在这里,我们综述了与冠状病毒相关的免疫障碍和免疫损伤的动物模型,特别是考虑了冠状病毒替代物、病毒修饰、刺突蛋白和基因片段等方面。对冠状病毒相关免疫损伤的小鼠模型的评估可能有助于建立标准化的动物模型,从而可应用于各种研究领域,如疾病发生和发展过程、疫苗效果评估以及冠状病毒相关免疫障碍的治疗。COVID-19 是一种复杂的疾病,动物模型无法全面总结疾病过程。遗传技术的应用可能会改变这种状况。